Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
West Pharmaceutical Services, Inc. (WST) had Free Cash Flow of $128.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$872.30M |
|
$154.00M |
|
$543.10M |
|
$329.20M |
|
$693.20M |
|
$179.10M |
|
$1.00M |
|
$180.10M |
|
$180.10M |
|
$147.90M |
|
$154.00M |
|
$154.00M |
|
$147.90M |
|
$179.10M |
|
$225.30M |
|
70.80M |
|
71.30M |
|
$2.17 |
|
$2.15 |
|
| Balance Sheet Financials | |
$1.81B |
|
$1.69B |
|
$2.27B |
|
$4.08B |
|
$640.50M |
|
$202.90M |
|
$445.70M |
|
$1.09B |
|
$2.99B |
|
$2.88B |
|
$2.99B |
|
70.40M |
|
| Cash Flow Statement Financials | |
$213.90M |
|
$-85.90M |
|
$-473.50M |
|
$791.30M |
|
$435.80M |
|
$-355.50M |
|
$17.50M |
|
$-31.50M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.82 |
|
-- |
|
-- |
|
0.06 |
|
0.07 |
|
37.74% |
|
20.53% |
|
20.53% |
|
-- |
|
20.65% |
|
17.65% |
|
|
Free Cash Flow |
$128.00M |
-- |
|
-- |
|
-- |
|
0.21 |
|
1.21 |
|
1.23 |
|
73.46 |
|
5.15% |
|
5.36% |
|
3.78% |
|
4.82% |
|
$42.47 |
|
$1.80 |
|
$3.00 |
|